1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on November 19, 2024

Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?
AMGN

Insider Monkey

a day ago

Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
AMGN

Zacks

a day ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

AMGN

Morningstar Research

a day ago

Analyst Report: Amgen Inc.

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
AMGN

Yahoo Finance

3 days ago

The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
AMGN

Motley Fool

3 days ago

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious

The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period
AMGN

Simply Wall St.

3 days ago

The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period

AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
AMGN

PR Newswire

5 days ago

AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024

Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
AMGN

Zacks

5 days ago

Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate

5 Healthcare Stocks to Buy in a Beaten-Up Sector
AMGN

Barrons.com

5 days ago

5 Healthcare Stocks to Buy in a Beaten-Up Sector

2 Dividend Stocks to Buy Hand Over Fist in November
AMGN

Motley Fool

5 days ago

2 Dividend Stocks to Buy Hand Over Fist in November

AMGN

Investing.com

5 days ago

Citi initiates coverage on 5 new biotech stocks

Amgen speaks out about bone density concerns with obesity drug
AMGN

Clinical Trials Arena

5 days ago

Amgen speaks out about bone density concerns with obesity drug

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?
AMGN

Investor's Business Daily

6 days ago

Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?

Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
AMGN

Benzinga

6 days ago

Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density

AMGN

MT Newswires

6 days ago

HSBC Adjusts Price Target on Amgen to $385 From $369

AMGN

MT Newswires

6 days ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

AMGN

MT Newswires

6 days ago

Amgen Rejects Connection Between Potential Weight-Loss Drug to Bone-Density Loss

Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
AMGN

BioPharma Dive

6 days ago

Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing

Amgen dismisses bone density concerns related to its new weight-loss drug
AMGN

Reuters

6 days ago

Amgen dismisses bone density concerns related to its new weight-loss drug

AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
AMGN

PR Newswire

6 days ago

AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA

Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot
AMGN

Investor's Business Daily

7 days ago

Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot

As Trump Readies a Reset of Antitrust Policy, Look to These Sectors for Deals
AMGN

The Wall Street Journal

9 days ago

As Trump Readies a Reset of Antitrust Policy, Look to These Sectors for Deals

AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
AMGN

PR Newswire

11 days ago

AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
AMGN

Pharmaceutical Technology

11 days ago

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

AMGN

Morningstar Research

11 days ago

Analyst Report: Amgen Inc.

AMGN

Benzinga

11 days ago

AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
AMGN

Clinical Trials Arena

11 days ago

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

AMGN

MT Newswires

11 days ago

Amgen's Chronic Rhinosinusitis Drug Meets Main, Secondary Goals in Phase 3 Trial

TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
AMGN

PR Newswire

11 days ago

TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Amgen Insiders Sold US$4.0m Of Shares Suggesting Hesitancy
AMGN

Simply Wall St.

12 days ago

Amgen Insiders Sold US$4.0m Of Shares Suggesting Hesitancy

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
AMGN

Zacks

13 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
AMGN

Zacks

14 days ago

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?
AMGN

Insider Monkey

15 days ago

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?

Big Pharma’s Obesity Bonanza Faces New Tests
AMGN

The Wall Street Journal

15 days ago

Big Pharma’s Obesity Bonanza Faces New Tests

Amgen Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
AMGN

Simply Wall St.

17 days ago

Amgen Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value
AMGN

GuruFocus.com

18 days ago

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value

AMGN

Argus Research

18 days ago

Analyst Report: AMGEN Inc.

AMGN

Argus Research

18 days ago

Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHC

Amgen Third Quarter 2024 Earnings: EPS Beats Expectations
AMGN

Simply Wall St.

18 days ago

Amgen Third Quarter 2024 Earnings: EPS Beats Expectations

Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
AMGN

GuruFocus.com

18 days ago

Decoding Amgen Inc (AMGN): A Strategic SWOT Insight

Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight
AMGN

Pharmaceutical Technology

19 days ago

Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight

AMGN

Thomson Reuters StreetEvents

19 days ago

Q3 2024 Amgen Inc Earnings Call

AMGN

MT Newswires

19 days ago

UBS Adjusts Price Target on Amgen to $326 From $335, Maintains Neutral Rating

AMGN

MT Newswires

19 days ago

Goldman Sachs Adjusts Price Target on Amgen to $375 From $369, Maintains Buy Rating

AMGN

Morningstar Research

19 days ago

Analyst Report: Amgen Inc.

Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus
AMGN

Zacks

19 days ago

Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus

AMGN

MT Newswires

19 days ago

Morgan Stanley Raises Price Target on Amgen to $322 From $319, Keeps Equalweight Rating

Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
AMGN

GuruFocus.com

19 days ago

Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...

Amgen (AMGN) Q3 2024 Earnings Call Transcript
AMGN

Motley Fool

20 days ago

Amgen (AMGN) Q3 2024 Earnings Call Transcript

Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics
AMGN

Zacks

20 days ago

Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics

Amgen (AMGN) Beats Q3 Earnings Estimates
AMGN

Zacks

20 days ago

Amgen (AMGN) Beats Q3 Earnings Estimates

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO
AMGN

Investor's Business Daily

20 days ago

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

AMGN

MT Newswires

20 days ago

Amgen Q3 Non-GAAP Earnings, Revenue Increase; 2024 Outlook Updated

AMGN

Associated Press Finance

20 days ago

Amgen: Q3 Earnings Snapshot

Amgen posts higher profit, obesity data on track for late this year
AMGN

Reuters

20 days ago

Amgen posts higher profit, obesity data on track for late this year

AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
AMGN

PR Newswire

20 days ago

AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.
AMGN

Investor's Business Daily

21 days ago

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 79%
AMGN

Simply Wall St.

21 days ago

Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 79%

2 Reliable Dividend Stocks You Can Buy and Hold Forever
AMGN

Motley Fool

24 days ago

2 Reliable Dividend Stocks You Can Buy and Hold Forever

AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND
AMGN

PR Newswire

25 days ago

AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND

AMGN

MT Newswires

25 days ago

Amgen Likely to See Q3 Miss, Long-Term Positive Revenue Growth, Oppenheimer Says

What Lies in Store for Healthcare ETFs in Q3 Earnings?
AMGN

Zacks

25 days ago

What Lies in Store for Healthcare ETFs in Q3 Earnings?

Ahead of Amgen (AMGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
AMGN

Zacks

25 days ago

Ahead of Amgen (AMGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
AMGN

Zacks

25 days ago

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

GSK invests $800M in manufacturing; Amgen sets small discount for Eylea biosimilar
AMGN

BioPharma Dive

25 days ago

GSK invests $800M in manufacturing; Amgen sets small discount for Eylea biosimilar

AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS
AMGN

PR Newswire

a month ago

AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
AMGN

Zacks

a month ago

Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Amgen (AMGN) Dips More Than Broader Market: What You Should Know
AMGN

Zacks

a month ago

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

Amgen Gears Up to Report Q3 Earnings: Here's What to Expect
AMGN

Zacks

a month ago

Amgen Gears Up to Report Q3 Earnings: Here's What to Expect

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AMGN

Zacks

a month ago

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Amgen plans launch of Eylea biosimilar after court ruling
AMGN

BioPharma Dive

a month ago

Amgen plans launch of Eylea biosimilar after court ruling

AMGN

MT Newswires

a month ago

Update: Amgen to Launch Biosimilar of Eylea After Court Denies Regeneron's Stay Request

AMGN

MT Newswires

a month ago

Market Chatter: Amgen to Launch Biosimilar of Eylea After Court Denies Regeneron's Stay Request

Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 38% Undervaluation?
AMGN

Simply Wall St.

a month ago

Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 38% Undervaluation?

Why Amgen (AMGN) Dipped More Than Broader Market Today
AMGN

Zacks

a month ago

Why Amgen (AMGN) Dipped More Than Broader Market Today

AMGN

MT Newswires

a month ago

TD Cowen Adjusts Price Target on Amgen to $383 From $381

Why this largely unknown company is one analyst's top biotech pick
AMGN

Yahoo Finance Video

a month ago

Why this largely unknown company is one analyst's top biotech pick

Is Amgen Stock a Buy?
AMGN

Motley Fool

a month ago

Is Amgen Stock a Buy?

High Growth Tech Stocks to Watch in October 2024
AMGN

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in October 2024

Regeneron price target lowered to $1,137 from $1,200 at Truist
AMGN

TipRanks

a month ago

Regeneron price target lowered to $1,137 from $1,200 at Truist

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts
AMGN

Zacks

a month ago

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

AMGN

MT Newswires

a month ago

Amgen Says Phase 3 Uplizna Trial in Generalized Myasthenia Gravis Meets Primary Endpoint

AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
AMGN

PR Newswire

a month ago

AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
AMGN

Investor's Business Daily

a month ago

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

AMGN

MT Newswires

a month ago

Amgen Seeing Muted Upside Potential for Drug Pipeline, Truist Says

Amgen Stock Falls. The Obesity Drug Landscape Is Getting Crowded.
AMGN

Barrons.com

a month ago

Amgen Stock Falls. The Obesity Drug Landscape Is Getting Crowded.

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
AMGN

Zacks

a month ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen Inc. (NASDAQ:AMGN) Delivered A Better ROE Than Its Industry
AMGN

Simply Wall St.

a month ago

Amgen Inc. (NASDAQ:AMGN) Delivered A Better ROE Than Its Industry

AMGN

MT Newswires

a month ago

Truist Downgrades Amgen to Hold, Adjusts Price Target to $333 From $320

AMGN

MT Newswires

a month ago

Morgan Stanley Adjusts Price Target on Amgen to $319 From $316

2 Top Dividend Stocks to Buy Hand Over Fist Right Now
AMGN

Motley Fool

a month ago

2 Top Dividend Stocks to Buy Hand Over Fist Right Now

Amgen (AMGN) Dips More Than Broader Market: What You Should Know
AMGN

Zacks

a month ago

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

2 Biotech Stocks to Buy Hand Over Fist in October
AMGN

Motley Fool

a month ago

2 Biotech Stocks to Buy Hand Over Fist in October

AMGN

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Amgen to $300 From $290, Maintains Neutral Rating

Amgen and MediLink to collaborate on SCLC combination therapy
AMGN

Pharmaceutical Technology

a month ago

Amgen and MediLink to collaborate on SCLC combination therapy

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value
AMGN

GuruFocus.com

a month ago

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value

Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
AMGN

Motley Fool

a month ago

Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks

Insiders At Amgen Sold US$4.0m In Stock, Alluding To Potential Weakness
AMGN

Simply Wall St.

a month ago

Insiders At Amgen Sold US$4.0m In Stock, Alluding To Potential Weakness

3 Magnificent Dividend Stocks to Buy in October
AMGN

Motley Fool

a month ago

3 Magnificent Dividend Stocks to Buy in October

Amgen Inc. (AMGN): A Buzzing AI Health Stock to Add to Your Portfolio
AMGN

Insider Monkey

a month ago

Amgen Inc. (AMGN): A Buzzing AI Health Stock to Add to Your Portfolio

Share on Social Networks: